


| Key | % Net Assets |
|---|---|
| 5.1% | |
| 5.0% | |
| 5.0% | |
| 4.9% | |
| 80% |
| Name | % Net Assets |
|---|---|
| Vodafone Group | 5.1% |
| GLAXOSMITHKLINE | 5.0% |
| Astrazeneca | 5.0% |
| Unilever | 4.9% |
| British American Tobacco | 4.6% |
| BP | 4.2% |
| Royal Dutch Shell B | 4.1% |
| Centrica | 3.9% |
| BT group | 3.7% |
| BG Group | 3.4% |
No asset data available.
| Date | n/a |
|---|---|
| Bid | 0.00 |
| Offer | 0.00 |
| Currency | n/a |
| Change | 0.00 |
| % | n/a |
| YTD change | 0.00 |
| YTD % | n/a |
| Fund Inception | 28/02/2002 |
|---|---|
| Fund Manager | Daniel Roberts |
| TER | - |
| Minimum Investment | |
|---|---|
| Initial | 1000 |
| Additional | n/a |
| Savings | 100 |
| Charges | |
|---|---|
| Initial | 5.00% |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| No risk data available. | |
You are here: research